Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1

Circulation Research

Volumn 83, Issue 8, 1998, Pages 832-840

  Wang, He ^a   Keiser, Joan A ^a  

^a PFIZER INC   (United States)

Author keywords

Angiogenesis; Flt 1; Matrix metalloproteinase; Vascular endothelial growth factor; Vascular smooth muscle cell

Indexed keywords

MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032547763     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.8.832     Document Type: Article

References (48)

1. Beck L Jr. D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J. 1997;11:365-373.
2. Mohle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A. 1997;94:663-668.
3. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
4. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269: 26988-26995.
5. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an iso-form specific receptor for vascular endothelial growth factor. Cell. 1998;92:735-745.
6. Clauss M, Weich H, Breier G, Knies U, Rock W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor flt-1 mediates biological activities. J Biol Chem. 1996;271:17629-17634.
7. Liu B, Earl HM, Baban D, Shoaibi M, Fabra A, Kerr DJ, Seymour LW. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun. 1995;217:721-727.
8. Takagi H, King GL, Aiello LP. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes. 1996;45:1016-1023.
9. Nehls V, Denzer K, Drenckhahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 1992;270: 469-474.
10. Nicosia RF, Villaschi S. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest. 1995;73:658-666.
11. Stein J, Drenckhahn D, Nehls V. Development of pericyte-like cells during angiogenesis in quail chick chimeras as detected by combined Feulgen reaction and immunohistochemistry. Anat Anz. 1996;178: 153-158.
12. D'Amore PA. Capillary growth: a two-cell system. Semin Cancer Biol. 1992;3:49-56.
13. Schonbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes. Circ Res. 1997;81: 448-454.
14. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. Primate smooth muscle cell migration from aortic expiants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinase 2 and 9. Circulation. 1997;96: 3555-3560.
15. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41-54.
16. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinase-1. J Natl Cancer Inst. 1994;856: 299-304.
17. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol. 1996;7:147-154.
18. Wang H, Keiser JA. Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation. J Vasc Res. 1997;35:45-54.
19. Galis Z, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2501.
20. Fabunmi RP, Baker AH, Murray EJ, Booth RFG, Newby AC. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinase and tissue inhibitors of metalloproteinase-1, -2, -3 in rabbit aortic smooth muscle cell. Biochem J. 1996;315:335-342.
21. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992;153:557-562.
22. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5:519-524.
23. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
24. Folkman J. Clinical application of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.
25. Hansen-Smith FM, Hudlicka O, Egginton S. In vivo angiogenesis in adult rat skeletal muscle: early changes in capillary network architecture and ultrastructure. Cell Tissue Res. 1996;286:123-136.
26. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of TGF-β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A. 1989;86:4544-4548.
27. Rohovsky SA, Hirschi KK, D'Amore PA. Growth factor effects on a model of vessel formation. Surg Forum. 1996;47:390-391.
28. Cuevas P, Gutierrez-Diaz JA, Reimers D, Dujovny M, Diaz FG, Ausman JI. Pericyte endothelial gap junctions in human cerebral capillaries. Anat Embryol (Berl). 1984;170:155-159.
29. Stromblad S, Cheresh DA. The role of cell adhesion molecules in angiogenesis. Trends Cell Biol. 1996;6:462-468.
30. Schlingemann RO, Oosterwijk E, Wesseling P, Rietveld FJR, Ruiter DJ. Aminopeptidase A is a constituent of activated pericytes in angiogenesis. J Pathol. 1996;179:436-442.
31. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 1995;10:135-147.
32. Matrisian LM. Matrix metalloproteinase gene expression. Ann N Y Acad Sci. 1994;732:42-50.
33. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell. 1997;90:739-751.
34. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parke WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol. 1997;137:1445-1457.
35. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science. 1997;277:225-228.
36. Moscatelli DA, Rifkin DB, Jaffe EA. Production of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations. Exp Cell Res. 1985;156:379-390.
37. Johnson MD, Kim HC, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol. 1994;160:194-202.
38. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, Giavazzi R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst. 1995;87:293-298.
39. Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 1996;16:28-33.
40. Kenagy RD, Vergel S, Mattsson E, Bendeck M, Reidy MA, Clowes AW. The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arterioscler Thromb Vasc Biol 1996;16:1373-1382.
41. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries: a novel role for reactive oxygen species in atherosclerosis. Circ Res. 1997;81:24-33.
42. Hamdan AD, Aiello LP, Misare BD, Contreras MA, King GL, LoGerfo FW, Quist WC. Vascular endothelial growth factor expression in canine peripheral vein bypass grafts. J Vasc Surg. 1997;26:79-86.
43. Bendeck M, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
44. Southgate KM, Davies M, Booth RF, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem J. 1992;288:93-99.
45. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber J, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 1996;94:1074-1082.
46. Couper LL, Bryant SR, Eldrup-Jorgensen J, Bredenberg CE, Lindner V. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth-2 in vascular smooth muscle cell in vivo via expression of fms-like tyrosine kinase-1. Circ Res. 1997;81:932-939.
47. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91: 2793-2801.
48. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879-886.